{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:18:22Z","timestamp":1792732702126,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","award":["NCT03905694"],"award-info":[{"award-number":["NCT03905694"]}],"id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.gim.2021.10.024","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T01:15:28Z","timestamp":1638926128000},"page":"654-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children"],"prefix":"10.1016","volume":"24","author":[{"given":"David J.","family":"Sas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Magen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Shasha-Lavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indra","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Sellier-Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Seddighzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahru","family":"Habtemariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji P.","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov","family":"Frishberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Becker-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimrit","family":"Tzvi Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Ben-Shalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Berdaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Bockenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl H.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Desch\u00eanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dossier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Doye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat Feraru","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Hohenadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Kaguelidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina Libinson","family":"Zebegret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Lieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Maisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn S.","family":"Milliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Plonsky Toder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Portefaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ranchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choni","family":"Rinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesa","family":"Schalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poyyapakkam R.","family":"Srivaths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Van't Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Weinbrand-Goichberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irith","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gim.2021.10.024_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00240-018-1093-3","article-title":"Recent advances in the identification and management of inherited hyperoxalurias","volume":"47","author":"Sas","year":"2019","journal-title":"Urolithiasis"},{"issue":"10","key":"10.1016\/j.gim.2021.10.024_bib2","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.gim.2021.10.024_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ki.2009.435","article-title":"Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome","volume":"77","author":"Harambat","year":"2010","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.gim.2021.10.024_bib4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ki.2014.222","article-title":"Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type","volume":"86","author":"Mandrile","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.gim.2021.10.024_bib5","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Primary hyperoxaluria","author":"Danpure","year":"2019"},{"issue":"3","key":"10.1016\/j.gim.2021.10.024_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/1319-2442.182389","article-title":"Primary hyperoxaluria in infants","volume":"27","author":"Jellouli","year":"2016","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"7","key":"10.1016\/j.gim.2021.10.024_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMra1301564","article-title":"Primary hyperoxaluria","volume":"369","author":"Cochat","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.gim.2021.10.024_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biotechadv.2019.04.012","article-title":"RNAi therapeutic and\u00a0its innovative biotechnological evolution","volume":"37","author":"Weng","year":"2019","journal-title":"Biotechnol Adv"},{"issue":"6","key":"10.1016\/j.gim.2021.10.024_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.gim.2021.10.024_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.gim.2021.10.024_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","article-title":"Mechanism-based concepts of size and maturity in pharmacokinetics","volume":"48","author":"Anderson","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.gim.2021.10.024_bib12","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.urology.2009.08.061","article-title":"Twenty-four hour and spot urine metabolic evaluations: correlations versus agreements","volume":"75","author":"Hong","year":"2010","journal-title":"Urology"},{"issue":"Pt 1","key":"10.1016\/j.gim.2021.10.024_bib13","first-page":"113","article-title":"The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary\u00a0hyperoxaluria: review of data from a referral centre","volume":"52","author":"Clifford-Mobley","year":"2015","journal-title":"Ann Clin\u00a0Biochem"},{"issue":"1","key":"10.1016\/j.gim.2021.10.024_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00858966","article-title":"Urinary calcium and oxalate excretion in children","volume":"9","author":"Reusz","year":"1995","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.gim.2021.10.024_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s002470050539","article-title":"Observer reliability in grading nephrocalcinosis on ultrasound examinations in children","volume":"29","author":"Dick","year":"1999","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.gim.2021.10.024_bib16","series-title":"GeneReviews [Internet]","article-title":"Primary hyperoxaluria type 1","author":"Milliner","year":"1993"},{"issue":"2","key":"10.1016\/j.gim.2021.10.024_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S0272-6386(99)70380-X","article-title":"Urinary oxalate and urate to creatinine ratios in a healthy pediatric population","volume":"34","author":"Matos","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.gim.2021.10.024_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ped4.12004","article-title":"RNAi technique, how far is it from pediatrics?","volume":"1","author":"Zhaori","year":"2017","journal-title":"Pediatr Investig"},{"issue":"1","key":"10.1016\/j.gim.2021.10.024_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2215\/CJN.02810315","article-title":"Predictors of incident ESRD among patients with primary hyperoxaluria presenting prior to kidney failure","volume":"11","author":"Zhao","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.gim.2021.10.024_bib20","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00467-010-1593-z","article-title":"Excellent renal function and reversal of\u00a0nephrocalcinosis 8 years after isolated liver transplantation in an infant with primary hyperoxaluria type 1","volume":"25","author":"Galanti","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.gim.2021.10.024_bib21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ndt\/gfq353","article-title":"Pre-emptive liver transplantation for primary hyperoxaluria (PH-I) arrests long-term renal function deterioration","volume":"26","author":"Perera","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.gim.2021.10.024_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/ajt.12706","article-title":"Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant","volume":"14","author":"Lorenz","year":"2014","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.gim.2021.10.024_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1053\/j.ajkd.2020.07.017","article-title":"Recovery from dialysis in patients with primary hyperoxaluria type 1 treated with pyridoxine: a report of 3 cases","volume":"77","author":"Lorenz","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.gim.2021.10.024_bib24","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2215\/CJN.13821119","article-title":"End points for clinical trials in primary hyperoxaluria","volume":"15","author":"Milliner","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"13","key":"10.1016\/j.gim.2021.10.024_bib25","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi\u00a0therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.gim.2021.10.024_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ki.2014.298","article-title":"Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria","volume":"87","author":"Tang","year":"2015","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.gim.2021.10.024_bib27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2215\/CJN.14730920","article-title":"Phase 1\/2 study of lumasiran for treatment of primary hyperoxaluria type 1: a placebo-controlled randomized clinical trial","volume":"16","author":"Frishberg","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.gim.2021.10.024_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jmedgenet-2014-102529","article-title":"Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria","volume":"51","author":"Frishberg","year":"2014","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.gim.2021.10.024_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54363","article-title":"Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria","volume":"9","author":"McGregor","year":"2020","journal-title":"eLife"},{"issue":"11","key":"10.1016\/j.gim.2021.10.024_bib30","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00467-017-3741-1","article-title":"Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria","volume":"32","author":"Clifford-Mobley","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.gim.2021.10.024_bib31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/BF01799176","article-title":"Persistent glycolic aciduria in a healthy child with normal alanine-glyoxylate aminotransferase activity","volume":"19","author":"Craigen","year":"1996","journal-title":"J\u00a0Inherit Metab Dis"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021053764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021053764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:46:21Z","timestamp":1778798781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021053764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1098360021053764"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2021.10.024","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2021.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}]}}